StockData
Beta Bionics, Inc. logo

Beta Bionics, Inc. (BBNX) stock

BBNXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 11/304% below fair value
$14.72−0.49 (-3.22%)

Close on Nov 17, 2026Market cap $800.28MP/E –Yield –

Beta Bionics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Beta Bionics's price to book ratio was 3.1× on Nov 11, 2026, against 4.7× a year earlier.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20263.1×−1.4
2025Dec 31, 20254.5×–

More Beta Bionics figures

See a number that looks wrong?